InsidersTradesSigma
Track the 일신바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 일신바이오 has published 7 public disclosures. The latest transaction was reported on 4 June 2026 (Purchase). Among the most active insiders: 홍성대. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Ilshin Bio 位于医疗保健和制药领域，在XKRX市场上市。该公司专注于生物制药产品的开发。